Ira Duarte

Insider Reports History

Entity
Individual
Location
1255 Crescent Green Drive, Suite 250, Cary, NC
Signature
/s/ Kathryn Lester Attorney-in-Fact for Ira Duarte
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ira Duarte:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Financial Officer Employee Stock Option (Right to Buy) 372K $662K $1.78 Jan 19, 2024 Direct
TerrAscend Corp. Director Common Shares 296K $595K $2.01 Jun 17, 2024 Direct
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Financial Officer Common Stock 108K $285K $2.64 Oct 19, 2024 Direct
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Financial Officer Restricted Stock Units 50.4K $133K $2.64 Oct 19, 2024 Direct

Insider Reports Filed by Ira Duarte

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HRTX HERON THERAPEUTICS, INC. /DE/ Oct 19, 2024 2 $0 4 Oct 21, 2024 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Jul 19, 2024 2 $0 4 Jul 22, 2024 EVP, Chief Financial Officer
TSNDF TerrAscend Corp. Jun 17, 2024 1 $0 4 Jun 20, 2024 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jun 16, 2024 2 $0 4 Jun 17, 2024 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Apr 19, 2024 3 -$2.96K 4 Apr 19, 2024 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Jan 19, 2024 2 $0 4 Jan 19, 2024 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Nov 16, 2023 1 $75.6K 4 Nov 17, 2023 EVP, Chief Financial Officer
TSNDF TerrAscend Corp. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jun 16, 2023 0 $0 3 Jun 23, 2023 EVP, Chief Financial Officer
TSNDF TerrAscend Corp. Dec 1, 2022 0 $0 3 Dec 9, 2022 Director